Table 1.

Characteristics of lymph node stations at ¹⁸F-Alfatide PET/CT.

Variables	NSCLC			AC			SCC
	Malignant	Benign	P	Malignant	Benign	P	Malignant	Benign	P
SUVmax	2.5(1.1–3.8)	0.9(0.3–3.3)	<0.01	1.8(1.1–3.8)	0.95(0.3–2.5)	<0.01	1.7(1.4–2.2)	0.9(0.4–3.3)	<0.01
SUVmean	1.7(0.9–2.5)	0.8(0.3–2.6)	<0.01	1.45(0.9–2.5)	0.9(0.3–1.8)	<0.01	1.3(1.1–1.8)	0.8(0.4–2.6)	<0.01
SUVLN/PT	0.5(0.2–0.9)	0.2(0.1–1.0)	<0.01	0.31(0.2–0.6)	0.24(0.1–1.0)	<0.01	0.3(0.27–0.4)	0.2(0.1–0.6)	<0.01
SUVLN/MBP	2.2(0.8–3.5)	0.9(0.3–3.0)	<0.01	1.1(0.8–3.2)	0.8(0.4–2.2)	<0.01	1.9(1.6–2.0)	1.0(0.4–3.0)	<0.01
SUVLN/M	4.1(2.2–9.5)	1.7(0.6–4.7)	<0.01	3.0(2.2–9.8)	1.7(0.6–4.2)	<0.01	3.0(2.8–3.4)	1.6(0.8–4.7)	<0.01

All data represent median (range). NSCLC, non-small cell lung cancer; AC, adenocarcinoma; SCC, squamous cell carcinoma; P, P value; SUV, standardized uptake value; LN, lymph node; MBP, mediastinal blood pool; PT, primary tumor; M, muscle.